Acid Elution Immunoassay for Low-Level Biomarker Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing immunoassays face challenges in achieving high sensitivity due to the ratio of specific to non-specific binding, particularly at low antigen levels, which affects the detection of biomarkers like troponin I in early disease detection and patient triage.
Innovation Solution
The method involves preferentially eluting specific immune complexes over non-specific complexes using optimized elution conditions, combined with luminescent detection systems and amplification assays to enhance the signal-to-background ratio, thereby improving assay sensitivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If high sensitivity immunoassay is implemented to detect low antigen levels, then detection sensitivity is improved, but non-specific binding increases relative to specific binding
Solution Approach 1:
The patent applies parameter changes by optimizing elution conditions (pH, temperature, time) to selectively elute specifically bound antibody-antigen complexes while leaving non-specifically bound antibodies on the solid phase. This resolves the contradiction by changing the physical-chemical parameters of the elution process to enhance specific signal while suppressing non-specific background, thereby maintaining high detection sensitivity without being compromised by non-specific binding.
2Measurement precision
If elution conditions are optimized to preferentially elute specific immune complexes, then signal-to-background ratio is improved, but assay complexity increases
Solution Approach 1:
The patent applies preliminary action by pre-optimizing and establishing specific elution conditions (pH, temperature, duration) before the actual assay execution. The solid phase and antibodies are selected and prepared in advance to exhibit differential binding characteristics that can be exploited during elution. This resolves the contradiction by performing the complex optimization work beforehand, allowing the actual assay to follow a standardized protocol that achieves high signal-to-background ratio without requiring complex real-time adjustments.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method significantly enhances the sensitivity of immunoassays, allowing for accurate detection of low levels of biomarkers such as troponin I, meeting clinical guidelines for precision and reliability.
Implementation Method 1
fluorescently labeled antibody to form an immune complex on the solid phase. The fluorescent signal of eluted materials is calculated
Implementation Method 2
using luminescent-labeled antibody and acid elution protocols in a direct antibody binding assay
Data Source
AI summary
The present invention is directed to methods for increasing sensitivities of immunoassays. The invention utilizes an acid elution condition that preferentially elute specifically bound immune complexes over non-specifically bound complexes from a solid phase, and designs immunoassay protocols that improve the ratio of specific binding to non-specific binding and thereby improving assay sensitivity. The protocol determines the signal of the labeled immunocomplexes eluted from a solid phase.